Agnieszka Brojakowska

Agnieszka graduated with Honors from Skidmore College in 2017, completing her studies with a BA in Molecular and Cellular Biology and a minor in Computer Science. During her undergraduate career, she led several studies on understanding circadian dysregulation in Alzheimer’s, developing computational methods for assessing axon dynamics in fetal alcohol spectrum disorders, and developing transgenic zebrafish models for studying spinal cord injury recovery. After her undergrad, she spent four years working as a medical scribe and researcher at the Cardiovascular Research Institute at the Icahn School of Medicine at Mount Sinai (ISMMS). She led and operationalized the convalescent plasma program during the beginning of the COVID-19 pandemic, which ultimately resulted in the development of HIG at Mount Sinai in collaboration with Immunotek. Additionally, Agnieszka was the lead scientist on various NASA Human Research Program and Translational Research Institute for Space Health-funded projects in the Goukassian lab. These projects focused on elucidating acute and chronic effects of ionizing radiation on cardiovascular disease risks. Clinically, she is interested in cardio-oncology. As an MD/PhD candidate in the Department of Cell Biology, Agnieszka has joined Dr. Diane Krause's lab, where she is investigating the mechanisms by which the transcription factor RUNX1, a commonly mutated target in acute myeloid leukemia, regulates the fate of bipotent megakaryocyte-erythroid progenitors.